Seneca Biopharma, INC. December [·], 2020December • December 21st, 2020 • Seneca Biopharma, Inc. • Biological products, (no disgnostic substances)
This Lock-Up Agreement is being delivered to you in connection with the Securities Purchase Agreement (the "Securities Purchase Agreement"), dated as of December [·], 2020 by and among Leading BioSciences, Inc. ("Leading BioSciences"), Seneca Biopharma, Inc. to be renamed "Palisade Bio, Inc." ("Seneca") and the investors party thereto (the "Buyers"), with respect to the issuance of (i) shares of Leading BioSciences' preferred stock, par value $0.001 per share (the "Leading BioSciences Preferred Stock"), and (ii) two series of warrants (the "Warrants"), which Warrants will be exercisable to purchase shares of Seneca's common stock, par value $0.01 per share (the "Seneca Common Stock," and together with the Leading BioSciences' common stock, par value $0.001 per share, the "Common Stock"). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement.
Re: Commitment LetterDecember • December 10th, 2020 • Aytu Bioscience, Inc • Pharmaceutical preparations
Reference is made to that certain Loan and Security Agreement dated as of October 2, 2019 (as amended, restated, supplemented or otherwise modified from time to time, the “Loan Agreement”), by and among NEOS THERAPEUTICS, INC., a Delaware corporation (“Company”), NEOS THERAPEUTICS BRANDS, LLC, a Delaware limited liability company (“NT Brands”), NEOS THERAPEUTICS, LP, a Texas limited partnership (“NT LP”; together with Company, NT Brands and each other Person who joins this Agreement as a borrower from time to time, each a “Borrower” and collectively the “Borrowers”), NEOS THERAPEUTICS COMMERCIAL, LLC, a Delaware limited liability company (“NT Commercial”), and PHARMAFAB TEXAS, LLC, a Texas limited liability company (“NT PharmaFab”), as Loan Party Obligors, the Lenders party thereto from time to time and ENCINA BUSINESS CREDIT, LLC, as agent for the Lenders (in such capacity, “Agent”). Capitalized terms used but not defined herein shall have the meanings given to them in the Loan Agreem
December 19, 2007December • February 28th, 2008 • Alexander & Baldwin Inc • Water transportation
Reference is made to the Amended and Restated Note Agreement (the "Agreement") dated May 19, 2005, by and between Matson Navigation Company, Inc. (the "Company"), on the one hand, and the undersigned, on the other hand. Pursuant to paragraph 11C of the Agreement and for good and valuable consideration, the receipt of which is hereby acknowledged, the undersigned and the Company agree that:
December 3, 2008December • October 4th, 2010 • Comverse Technology Inc/Ny/ • Telephone & telegraph apparatus
December 4, 1996 Credit America Venture Capital, Inc. c/o Douglas W. Baena 4355 N.W. 128 Street Miami, Florida 33054 Mako Marine International, Inc. 4355 N.W. 128 Street Miami, Florida 33054 Gentlemen: We are this day executing and delivering a Stock...December • December 13th, 1996 • Mako Marine International Inc • Ship & boat building & repairing
We are this day executing and delivering a Stock Purchase Agreement (the "Stock Purchase Agreement") by and between Tracker Marine, L.P. ("Tracker") and Mako Marine International, Inc. ("Mako" or the "Company") and the Tracker/CAVC Stock Purchase Agreement (the "CAVC Agreement") by and between Tracker and Credit America Venture Capital, Inc. ("CAVC"). The CAVC Agreement contemplates the sale by CAVC to Tracker of 930,000 shares of Common Stock of Mako concurrently with the closing of the Stock Purchase Agreement. Subject to the terms hereof, Tracker hereby agrees to indemnify and hold harmless CAVC, its directors, officers, agents and employees and such persons, if any, who control CAVC within the meaning of Section 15 of the Securities Act of 1933 and the directors and officers of the Company (the "Indemnified Parties") against any and all losses, liabilities, claims, damages or expenses whatsoever (including, but not limited to, any and all legal or other expenses incurred in investi
